Ozempic and Wegovy associated with vision loss risk
Now that they’ve been on the market for several years, Ozempic — the injectable GLP-1 agonist drug for treating diabetes — and its lower-dose version, the weight loss “miracle” Wegovy — are practically household names. But the active ingredient in both, semaglutide, hasn’t been without concerns, the least of which may be acid reflux, nausea and vomiting, acute pancreatitis and gallbladder disease — tied to the way the drug works…